Sign in

NCT07237555Completed

CVL Risk After Severe Glaucoma Surgery

Comparison of the Likelihood of Side Effects Between Surgical Methods in Patients With Severe Stage Glaucoma

Source: ClinicalTrials.gov · Last updated 10 Sept 2026

Brief summary (registry, in English)

This retrospective cohort study analyzes risk factors for central visual loss (CVL) after severe-stage glaucoma surgery. The primary hypothesis is that 1) visual prognosis is determined primarily by early postoperative intraocular pressure (IOP) stability rather than surgical choice, and 2) the nature of risk (hypotony vs hypertension) is modified by baseline visual reserve. We analyzed outcomes in 523 patients with severe-stage glaucoma who underwent trabeculectomy or Ahmed glaucoma valve (AGV) implantation, focusing on the dichotomous risk profile stratified by baseline visual acuity.

Status (registry)
Completed
Study type
Observational
Enrollment
523 (actual)
First submitted
16 Nov 2025
Start date
27 Nov 2024
Primary completion date
26 Nov 2025
Lead sponsor
Gangnam Severance Hospital
Diseases
Glaucoma
NCT number
NCT07237555

What you commit to

  • Study type: Observational
  • Participants enrolled: 523
  • From 27 Nov 2024 to the primary completion date, 26 Nov 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • 1\. Patients who were unable to undergo visual field testing due to poor preoperative visual acuity.
    • 2\. Patients with central visual field defects caused by retinal or neurological diseases other than glaucoma.
    • 3\. Patients with false-positive or false-negative responses ≥33% on visual field testing.

Who the study is looking for

  • 1\. Patients who underwent trabeculectomy or Ahmed glaucoma valve implantation at Yonsei Medical Center between January 2005 and October 2024.
    • 2\. Glaucoma patients who underwent static quantitative perimetry (visual field test) before and after surgery.
    • 3\. Patients with a preoperative Mean Deviation (MD) of ≤ -20 dB.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Gangnam Severacne Hospital
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.